Security key
000899104
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 238,388,839
- Total 13F shares
- 16,954,991
- Share change
- -73,291
- Total reported value
- $77,991,000
- Price per share
- $4.60
- Number of holders
- 34
- Value change
- -$211,472
- Number of buys
- 22
- Number of sells
- 8
Report period
Q1 2018
Institutions
34
Top holders
10
ADMA full security history
Newer quarter: Q2 2018
Previous quarter: Q4 2017
ADMA BIOLOGICS, INC. SEC filings
ADMA BIOLOGICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 000899104
Recent filing periods:
Top shareholders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.6%
|
3,821,102
|
$12,266,000 | — | 31 Dec 2017 | |
| Aisling Capital LLC |
13F
|
Company |
1.5%
|
3,608,171
|
$11,582,000 | — | 31 Dec 2017 | |
| Consonance Capital Management LP |
13F
|
Company |
1.4%
|
3,367,635
|
$10,810,000 | — | 31 Dec 2017 | |
| Biomark Capital Management Co. LLC |
13F
|
Company |
0.6%
|
1,433,304
|
$4,601,000 | — | 31 Dec 2017 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.46%
|
1,102,200
|
$3,538,000 | — | 31 Dec 2017 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.4%
|
950,000
|
$3,050,000 | — | 31 Dec 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.27%
|
639,506
|
$2,053,000 | — | 31 Dec 2017 | |
| Iguana Healthcare Management, LLC |
13F
|
Company |
0.25%
|
600,000
|
$1,926,000 | — | 31 Dec 2017 | |
| MORGENS WATERFALL VINTIADIS & CO INC |
13F
|
Company |
0.21%
|
500,000
|
$1,605,000 | — | 31 Dec 2017 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.13%
|
312,500
|
$1,003,000 | — | 31 Dec 2017 | |
| FMR LLC |
13F
|
Company |
0.12%
|
278,600
|
$894,000 | — | 31 Dec 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
112,000
|
$359,000 | — | 31 Dec 2017 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.03%
|
67,647
|
$217,000 | — | 31 Dec 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
67,533
|
$217,000 | — | 31 Dec 2017 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
42,376
|
$136,000 | — | 31 Dec 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
31,405
|
$101,000 | — | 31 Dec 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
30,520
|
$98,000 | — | 31 Dec 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
25,421
|
$81,000 | — | 31 Dec 2017 | |
| Virtu Financial LLC |
13F
|
Company |
0.01%
|
23,188
|
$74,000 | — | 31 Dec 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
7,000
|
$22,000 | — | 31 Dec 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
3,774
|
$12,000 | — | 31 Dec 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
3,700
|
$12,000 | — | 31 Dec 2017 | |
| Advisory Services Network, LLC |
13F
|
Company |
0%
|
700
|
$2,000 | — | 31 Dec 2017 |
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q1 2018
As of 31 Mar 2018,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,954,991 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Aisling Capital LLC, Consonance Capital Management LP, Biomark Capital Management Co. LLC, VANGUARD GROUP INC, 683 Capital Management, LLC, Broadfin Capital, LLC, Iguana Healthcare Management, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, and MORGENS WATERFALL VINTIADIS & CO INC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
Q4 2017 holders
23
Q1 2018 holders
34
Holder diff
11
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.